Clonal hematopoiesis (CH) introduces a hematopoietic component into the molecular and immune landscape of solid tumors. Its interpretation depends on whether a variant is measured in blood, plasma...
<p><strong>Tác giả:</strong> Hang Su, Junli Tang, Linwei Li</p>
<p>Clonal hematopoiesis (CH) introduces a hematopoietic component into the molecular and immune landscape of solid tumors. Its interpretation depends on whether a variant is measured in blood, plasma or tumor tissue, which cells carry it, and when sampling occurs relative to treatment. Existing reviews have examined cancer-associated inflammation, therapy-related clonal selection and clinical outcomes; a less developed question is how these observations can be compared when they measure differen...</p>
<p>📄 DOI: <a href="https://doi.org/https://doi.org/10.3389/fcell.2026.1982408" target="_blank" rel="noopener">https://doi.org/10.3389/fcell.2026.1982408</a></p>
<p>📖 <a href="https://doi.org/https://doi.org/10.3389/fcell.2026.1982408" target="_blank" rel="noopener">Xem bài báo đầy đủ</a></p>
Bài viết được biên soạn lại bởi LIFVietnam. Nguồn tham khảo: OpenAlex
